WuXi AppTec’s Changzhou and Taixing API Sites Successfully Pass FDA Inspections
1 April 2025
No Comments
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industry, today announced that its Active Pharmaceutical Ingredient (API) manufacturing sites